OneArm2stage (Q86702)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: OneArm2stage |
Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | OneArm2stage |
Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes |
Statements
9 October 2023
0 references
Two-stage design for single-arm phase II trials with time-to-event endpoints (e.g., clinical trials on immunotherapies among cancer patients) can be calculated using this package. Two notable advantages of the package: 1) It provides flexible choices from three design methods (optimal, minmax, and admissible), and 2) the power ofthe design is more accurately calculated using the exact variance in theone-sample log-rank test. The package can be used for 1) planning the samplesizes and other design parameters, and 2) conducting the interim and finalanalyses for the Go/No-go decisions. More details about the design methodcan be found in: Wu, J, Chen L, Wei J, Weiss H, Chauhan A. (2020).<doi:10.1002/pst.1983>.
0 references
